# Eva Garland Consulting > Eva Garland Consulting \(EGC\) is an Inc\. 5000 fastest growing consulting firm that assists scientists and entrepreneurs in securing and managing resources to accelerate development of their innovative technologies\. Generated by Yoast SEO v27.9, this is an llms.txt file, meant for consumption by LLMs. ## Pages - [Accounting \& Compliance](https://www.evagarland.com/accounting/) - [Blogs \& Webcasts](https://www.evagarland.com/resources/blogs-webcasts/) - [Homepage](https://www.evagarland.com/) - [NIH Applicant Assistance Program](https://www.evagarland.com/our-impact/partnerships/nih-aap/) - [NCI SBIR/STTR Training and Entrepreneurship Program](https://www.evagarland.com/our-impact/partnerships/nci-sbir-sttr-training-program/) ## Posts - [A New Year Checklist: Key Compliance and Tax Deadlines for 2026](https://www.evagarland.com/key-tax-and-compliance-dates-for-2026/): Here are some key dates to keep in mind for organizations with a December 31st fiscal year\-end\. Early planning for these deadlines can help avoid surprises and ensure smoother operations as the year gets underway\. - [Why Do I Have to Keep Timesheets for My SBIR Grant?](https://www.evagarland.com/why-keep-timesheets-for-sbir-grant/) - [Top 10 Compliance Pitfalls Every New SBIR Awardee Should Know](https://www.evagarland.com/top-10-compliance-pitfalls-every-new-sbir-awardee-should-know/) - [The Future of Non\-Dilutive Funding in an AI World](https://www.evagarland.com/non-dilutive-funding-in-an-ai-world/): Learn how the NIH JIT process works, what documents are required, and how to respond to a JIT request\. Expert guidance for SBIR/STTR applicants\. - [Join EGC at BIO 2026](https://www.evagarland.com/egc-reception-bio-2026/) ## Showcase - [Thymmune Therapeutics](https://www.evagarland.com/showcase/thymmune-therapeutics/): $58M ARPA\-H Award Advances Next\-Generation Thymic Cell Therapies\.\.\. - [Transmural Systems](https://www.evagarland.com/showcase/transmural-systems/): $36M\+ Funding Accelerates Innovative Cardiology Device Development\.\.\. - [WinSanTor](https://www.evagarland.com/showcase/winsantor/): Over $40M in Funding Propels Neuropathy Therapy to Phase 3 Clinical Trials\.\.\. - [Medgene](https://www.evagarland.com/showcase/medgene/): Veterinary Diagnostics and Vaccines Company Receives USDA, NIH, and DHA Funding\.\.\. - [PediaMetrix](https://www.evagarland.com/showcase/pediametrix/): NIH and NSF Funding Powers PediaMetrix's AI\-Driven Pediatric Screening Platform\.\.\. ## Optional - [Sitemap index](https://www.evagarland.com/sitemap_index.xml)